March 5, 2026
1 min read

Forma Life Sciences launches with oral solid dose focus, joining class of new CDMOs

Forma Life Sciences, which inherited BioDuro’s California operations earlier this year, officially launched as a CDMO with a focus on oral solid dosage drugs this week.

Leave a Reply

Your email address will not be published.

Previous Story

STAT+: RFK Jr. has wide discretion to choose evidence to support vaccine decisions, DOJ argues

Next Story

A month in, TrumpRx falls short of president’s grand promises

Previous Story

STAT+: RFK Jr. has wide discretion to choose evidence to support vaccine decisions, DOJ argues

Next Story

A month in, TrumpRx falls short of president’s grand promises

Latest from Blog

Go toTop